Last Updated : November 20, 2024
Reimbursement Review
Reimbursement Recommendations
We review drugs and make reimbursement recommendations to Canada's federal, provincial, and territorial public drug programs, with the exception of Quebec, to guide their drug reimbursement decisions.
Provisional Funding Algorithms
We provide advice to the drug programs on the appropriate place in therapy for the drugs within a particular therapeutic area, including the impact of new drugs on the sequencing of treatments for the purposes of reimbursement.
Health Technology Review
A customized review of a health technology. It may consist of one, or a combination, of the following: an environmental scan, a rapid review, a clinical review, a pharmacoeconomic review, and a review of patient perspectives, and it may also include the legal, ethical, social, implementation, environmental, and policy implications of the health technology. Appropriate use recommendations are provided where applicable.
Read the following process documents for more information about the services included within the Health Technology Review program. Process documents include details on each service, including how topics are identified and how each product is produced.
- Environmental Scan Process
- Overview of HTA and OU Medical Devices and Clinical Interventions
- Rapid Review Process
- Our Procedures for Implementation Advice for Health Technologies
- Procedures for Integrated Technology Reviews for Drugs
Horizon Scan
A high-level summary of a new or emerging health technology likely to have a significant impact on the delivery of health care in Canada.
Read the Horizon Scan process document for more information about the Horizon Scanning Service, including how topics are identified and how each Horizon Scan product is produced:
Other Programs and Services
Scientific Advice
Offers pharmaceutical companies advice on their early drug development plans from a health technology assessment perspective.
Last Updated : November 20, 2024